7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 
      
    		                 
      cash flows from operating activities
    		                 
      net income
    		-122,437,000 -99,653,000 -84,582,000 -74,763,000 -84,345,000 -57,166,000 -44,482,000 -38,292,000 -33,645,000 -29,090,000 -25,192,000 -26,123,000 -19,716,000 -18,466,000 -17,549,000 -17,289,000 -12,426,000 
      adjustments to reconcile net income to net cash from operating activities
    		                 
      stock-based compensation expense
    		22,314,000 22,074,000 20,380,000 16,138,000 15,459,000 15,125,000 13,857,000 7,490,000 6,854,000 5,848,000 5,371,000 3,017,000 2,654,000 2,449,000 2,205,000 1,388,000 1,373,000 
      net accretion on marketable securities
    		-2,187,000 -2,707,000 -4,283,000 -4,933,000 -2,921,000 -3,433,000 -3,382,000           
      change in fair value of related party revenue share liability
    		19,810,000 6,040,000 1,430,000 1,340,000              
      other non-cash
    		99,000 98,000 32,000               
      changes in operating assets and liabilities
    		                 
      prepaid expenses and other current assets
    		170,000 -684,000 818,000 -2,780,000 -3,102,000 -607,000 -1,074,000 -68,000 637,000 78,000 -3,000 -647,000 -1,503,000 -119,000 778,000 193,000 -396,000 
      other assets
    		-2,131,000 -1,778,000 -9,183,000 -121,000 -211,000 0 -3,076,000 -589,000 -351,000 -260,000 -228,000 -155,000 -114,000 -1,633,000 630,000 -362,000 -331,000 
      accounts payable
    		8,668,000 -12,823,000 20,940,000 -10,629,000 8,451,000 -5,993,000 4,122,000 -507,000 1,664,000 1,684,000 -672,000 2,485,000 592,000 -218,000 1,353,000 732,000 -914,000 
      accrued expenses and other liabilities
    		5,232,000 12,835,000 -373,000               
      net cash from operating activities
    		-70,462,000 -76,598,000 -54,821,000 -62,000,000 -45,817,000 -41,160,000 -36,087,000 -30,209,000 -22,981,000 -22,135,000 -24,414,000 -17,779,000 -18,175,000 -15,475,000 -13,542,000 -12,955,000 -11,400,000 
      cash flows from investing activities
    		                 
      purchases of marketable securities
    		-178,472,000 -158,074,000 -277,177,000 -312,495,000 -340,619,000 -88,830,000 -283,019,000 -166,722,000 -23,205,000 -81,611,000 -187,948,000 -162,623,000 -19,560,000 -16,790,000 -13,943,000 -164,476,000  
      proceeds from maturities and sales of marketable securities
    		   142,450,000              
      net cash from investing activities
    		53,971,000 77,478,000 25,417,000 -170,045,000 -212,906,000 16,208,000 -206,771,000 -56,261,000 38,400,000 1,594,000 -127,260,000 -65,401,000 17,567,000 24,112,000 13,057,000 -163,461,000  
      cash flows from financing activities
    		                 
      proceeds from issuance of common stock
    		4,773,000 5,755,000 4,554,000 8,787,000 550,455,000 4,293,000 6,452,000           
      payments of equity issuance costs
    		0 0 -6,000 -295,000              
      payments of insurance costs financed by a third-party
    		   0 0 -156,000 -466,000 -622,000 755,000 -364,000 -546,000 -546,000 612,000 -195,000 -781,000 -585,000  
      net cash from financing activities
    		4,773,000 5,755,000 4,548,000 8,492,000 550,267,000 4,137,000 5,986,000 333,423,000 2,143,000 1,298,000 -17,000 248,673,000 1,006,000 5,000 -768,000 -944,000 174,934,000 
      net increase in cash and cash equivalents
    		   -223,553,000    246,953,000 17,562,000   165,493,000 398,000 8,642,000 -1,253,000 -177,360,000 106,967,000 
      cash and cash equivalents at beginning of period
    		0 0 145,691,000 0 0 0 335,387,000 0 0 0 241,806,000 0 0 0 68,526,000 0 0 
      cash and cash equivalents at end of period
    		-11,718,000 6,635,000 120,835,000 -223,553,000 291,544,000 -20,815,000 98,515,000 246,953,000 17,562,000 -19,243,000 90,115,000 165,493,000 398,000 8,642,000 67,273,000 -177,360,000 106,967,000 
      supplemental disclosure of noncash investing and financing information:
    		                 
      operating lease right-of-use asset
    		0 0 798,000               
      equity issuance costs
    		   -231,000              
      proceeds from maturities of marketable securities
    		 235,552,000 302,594,000   105,038,000 76,248,000           
      net decrease in cash and cash equivalents
    		 6,635,000 -24,856,000   -20,815,000 -236,872,000    -151,691,000       
      adjustments to reconcile net income to net cash from operating activities:
    		                 
      accrued expenses
    		   13,748,000 4,252,000 10,914,000 -2,052,000 3,849,000 4,490,000 2,454,000 -1,152,000 4,477,000 -85,000 2,325,000 -1,235,000 2,169,000 1,293,000 
      supplemental disclosure of noncash financing information:
    		                 
      insurance premium financed by a third-party
    		       0    0    0  
      payments of public offering costs
    		                 
      cash flows from operating activities:
    		                 
      net accretion of discounts on marketable securities
    		                 
      changes in operating assets and liabilities:
    		                 
      cash flows from investing activities:
    		                 
      proceeds from sales and maturities of marketable securities
    		       110,461,000 61,605,000 83,205,000 60,688,000 97,222,000 37,127,000 40,902,000 27,000,000   
      cash flows from financing activities:
    		                 
      proceeds from public offerings, net of underwriting discounts and commissions
    		                 
      proceeds from exercise of stock options
    		                 
      proceeds from issuance of common stock under employee stock purchase plan
    		       194,000 0         
      public offering costs included in accounts payable
    		                 
      net amortization (accretion) of premiums (discounts) on marketable securities
    		        -2,630,000 -2,849,000 -2,538,000       
      proceeds from issuance of common stock upon option exercise
    		        1,388,000 1,469,000 619,000  394,000 200,000 13,000   
      payments of offering costs
    		        0 0 -90,000       
      change in fair value of preferred stock tranche rights
    		               0 0 
      non-cash interest income on promissory note
    		               0 0 
      proceeds from issuance of convertible preferred stock and preferred stock tranche rights, net of issuance costs
    		               0 0 
      proceeds from repayment of promissory note to stockholder
    		               0  
      settlement of notes payable and accrued interest for preferred stock
    		               0 0 
      conversion of convertible preferred stock to common stock upon initial public offering
    		               0  
      loss on extinguishment of debt
    		               0 0 
      settlement of preferred stock tranche rights
    		               0 0 
      unvested restricted common stock
    		                 
      options to purchase common stock
    		           -124,150,000      
      net amortization of premiums on marketable securities
    		            -3,000 187,000 276,000 214,000  
      proceeds from initial public offering, net of underwriting discounts and commissions
    		               0  
      payments of initial public offering costs
    		               -371,000 -2,229,000 
      initial public offering costs in accounts payable
    		                 
      initial public offering costs in accrued expenses and other current liabilities
    		                 
      issuance of promissory note to stockholder
    		                 
      •
    		                 
      1.
    		                 
      issuance of promissory note to founder
    		                 
      deferred offering costs in accounts payable and accrued expenses
    		                 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.